FDA Inspection 1004086 — Hillestad Pharmaceuticals USA, Inc.

Hillestad Pharmaceuticals USA, Inc. — FEI 2917045

The FDA completed an inspection of Hillestad Pharmaceuticals USA, Inc. on March 3, 2017 in Woodruff, WI. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Food/Cosmetics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 3, 2017
Fiscal Year
2017
Product Type
Food/Cosmetics
Project Area
Foodborne Biological Hazards
Location
Woodruff, WI (United States)

Citations

IDCFRDescription
1564521 CFR 111.455(c)Hold - mix-up, contamination, deterioration